Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1883516 | 0.85 | SLC1A2 (0.41) | GRIK1GRIK2DPP7SLC1A2SLC1A1 | |
| SCHEMBL1886382 | 0.84 | GRIK1 (0.50) | GRIK1GRIK2DPP7SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL1883990 | 0.82 | GRIK1 (0.49) | GRIK1GRIK2DPP7SLC1A2SLC1A1 | |
| SCHEMBL28855294 | 0.80 | CA2 (0.50) | GRIK1GRIK2SLC1A2SLC1A1LAP3 | |
| SCHEMBL30539139 | 0.80 | CA1 (0.53) | TP53OPRM1GPR84CA1CA2 | |
| SCHEMBL1412205 | 0.80 | CA2 (0.50) | GRIK1GRIK2SLC1A2SLC1A1LAP3 | |
| SCHEMBL8085531 | 0.80 | GPR84 (0.53) | TP53GPR84CA1CA2SPHK1 | |
| SCHEMBL28522786 | 0.80 | CA2 (0.50) | GRIK1GRIK2SLC1A2SLC1A1LAP3 | |
| SCHEMBL8813489 | 0.79 | GRIK1 (0.48) | GRIK1GRIK2DPP7SLC1A2SLC1A1 | |
| SCHEMBL16326700 | 0.79 | GRIK1 (0.52) | GRIK1GRIK2DPP7SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028671-A1 | Sequencing by Structure Assembly | HARVARD COLLEGE (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250369043-A1 | LINKERS AND METHODS FOR OPTICAL DETECTION AND SEQUENCING | ULTIMA GENOMICS INC (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4655423-A1 | INFERRING MICROORGANISM OF ORIGIN FOR ANTIMICROBIAL RESISTANCE MARKERS IN TARGETED METAGENOMICS | Illumina, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-12467086-B2 | Sequencing by structure assembly | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-11 | — | — | US | disclosed |
| EP-4612296-A1 | COMPOSITIONS AND METHODS FOR PURIFYING POLYRIBONUCLEOTIDES | Flagship Pioneering Innovations VI, LLC (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20250277224-A1 | COMPOSITIONS AND METHODS FOR PRODUCING CIRCULAR POLYRIBONUCLEOTIDES | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2025-09-04 | — | — | US | disclosed |
| US-12378600-B2 | Linkers and methods for optical detection and sequencing | ULTIMA GENOMICS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-12338474-B2 | Compositions and methods for producing circular polyribonucleotides | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2025-06-24 | — | — | US | disclosed |
| US-20250188505-A1 | PRODUCTION OF CIRCULAR POLYRIBONUCLEOTIDES IN A PROKARYOTIC SYSTEM | FLAGSHIP PIONEERING INNOVATIONS VII LLC (US) | 2025-06-12 | — | — | US | disclosed |
| WO-2025097012-A1 | METHODS OF SORTING SPERM BASED ON GENOTYPE | MAVEN BONNIE E J (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-113841078-A | Methods, devices and systems for analyte detection and analysis | 阿尔缇玛基因组学公司 | 2021-12-24 | — | — | CN | disclosed |
| CN-113795887-A | Method and system for sequence determination | 阿尔缇玛基因组学公司 | 2021-12-14 | — | — | CN | disclosed |
| CN-111527044-A | Method and system for sequence determination | 阿尔缇玛基因组学公司 | 2020-08-11 | — | — | CN | disclosed |
| US-20180340020-A1 | PEPTIDE-MEDIATED DELIVERY OF IMMUNOGLOBULINS ACROSS THE BLOOD-BRAIN BARRIER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2018-11-29 | — | — | US | disclosed |
| US-10072065-B2 | Peptide-mediated delivery of immunoglobulins across the blood-brain barrier | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2018-09-11 | — | — | US | disclosed |
| US-20170058017-A1 | PEPTIDE-MEDIATED DELIVERY OF IMMUNOGLOBULINS ACROSS THE BLOOD-BRAIN BARRIER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2017-03-02 | — | — | US | disclosed |
| US-8715923-B2 | Protein scaffolds and viral particles for detecting analytes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2014-05-06 | — | — | US | disclosed |
| US-20080220408-A1 | Non-enveloped virus particles comprising a plurality of detectable fluorescent labels for use in solid support for detecting preferential particles in solutions | THE GOVERNMENT OF THE US, AS REPRESENTED BY THE SE (US) | 2008-09-11 | — | — | US | disclosed |
| WO-2006124044-A2 | PROTEIN SCAFFOLDS AND VIRAL PARTICLES FOR DETECTING ANALYTES | GEORGE MASON UNIVERSITY (US) | 2006-11-23 | — | — | WO | disclosed |
| EP-0155503-A1 | Improvement in the dewatering of wet paper webs using mannich acrylamide polymers | AMERICAN CYANAMID COMPANY (US) | 1985-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028671-A1 | Sequencing by Structure Assembly | POLL, CPSF7, POLM | GRIK1 4874/4885GRIK2 4870/4885DPP7 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.